CINECA IRIS Institutional Research Information System

CREPALDI, Tiziana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.538
EU - Europa 2.913
AS - Asia 1.742
OC - Oceania 24
SA - Sud America 24
AF - Africa 21
Continente sconosciuto - Info sul continente non disponibili 20
Totale 9.282
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.434
CN - Cina 887
IT - Italia 434
IE - Irlanda 429
SG - Singapore 411
SE - Svezia 408
DE - Germania 376
UA - Ucraina 258
FR - Francia 224
FI - Finlandia 211
GB - Regno Unito 180
KR - Corea 169
AT - Austria 107
DK - Danimarca 102
CA - Canada 99
VN - Vietnam 75
PL - Polonia 59
JP - Giappone 58
IN - India 43
RU - Federazione Russa 33
BE - Belgio 28
ID - Indonesia 27
ES - Italia 25
EU - Europa 20
AU - Australia 19
HK - Hong Kong 17
BR - Brasile 16
NL - Olanda 14
TW - Taiwan 13
SN - Senegal 11
TR - Turchia 11
TH - Thailandia 8
MY - Malesia 7
IR - Iran 6
CH - Svizzera 5
MX - Messico 5
NZ - Nuova Zelanda 5
CL - Cile 3
CZ - Repubblica Ceca 3
LT - Lituania 3
NO - Norvegia 3
PH - Filippine 3
SK - Slovacchia (Repubblica Slovacca) 3
AE - Emirati Arabi Uniti 2
AR - Argentina 2
BO - Bolivia 2
ET - Etiopia 2
HU - Ungheria 2
PK - Pakistan 2
RO - Romania 2
SA - Arabia Saudita 2
BG - Bulgaria 1
BW - Botswana 1
BY - Bielorussia 1
CO - Colombia 1
EG - Egitto 1
IL - Israele 1
LU - Lussemburgo 1
MA - Marocco 1
MU - Mauritius 1
NA - Namibia 1
NG - Nigeria 1
PT - Portogallo 1
TG - Togo 1
ZM - Zambia 1
Totale 9.282
Salva come PNG Salva come JPEG
Città #
Chandler 706
Beijing 590
Dublin 429
Santa Clara 359
Ann Arbor 334
Singapore 333
Houston 222
Jacksonville 181
Nyköping 159
Fairfield 153
Ashburn 149
Torino 142
Medford 122
Villeurbanne 121
Vienna 106
Princeton 105
Wilmington 105
Columbus 102
Dearborn 88
Woodbridge 71
Toronto 69
Milan 68
Fremont 59
Dong Ket 54
Warsaw 52
Cambridge 49
Boardman 41
Seattle 41
Pisa 40
Verona 39
Guangzhou 38
Turin 30
Jakarta 27
Boston 24
Brussels 23
Munich 21
New York 20
Lachine 19
Falls Church 18
Nanjing 17
Redwood City 17
Norwalk 16
Shanghai 16
Nuremberg 15
Hefei 14
Helsinki 14
Los Angeles 12
Frankfurt am Main 11
Kunming 11
Pune 11
Madrid 10
London 9
Hangzhou 8
Wuhan 8
Auburn Hills 7
San Mateo 7
Hebei 6
Nuillé-sur-vicoin 6
Nürnberg 6
Rome 6
San Diego 6
Seoul 6
Shenzhen 6
Tokyo 6
Zhengzhou 6
Brisbane 5
Casalecchio di Reno 5
Central District 5
Chengdu 5
Hong Kong 5
Hsinchu 5
Leeds 5
Montrouge 5
Nanchang 5
Phoenix 5
Sydney 5
Tianjin 5
Xian 5
Zhenjiang 5
Amsterdam 4
Auburn 4
Central 4
Dallas 4
Elche 4
Fuzhou 4
Goiânia 4
Harbin 4
Jinan 4
Mountain View 4
Naples 4
Paris 4
Qingdao 4
University Park 4
Uppsala 4
Bangkok 3
Bydgoszcz 3
Chicago 3
Colton 3
Edmonton 3
Florence 3
Totale 5.714
Salva come PNG Salva come JPEG
Nome #
MicroRNAs in myocardial ischemia: identifying new targets and tools for treating heart disease. New frontiers for miR-medicine 291
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition) 274
Transgenic models of cardiac cachexia and cardiac effects of muscular atrophy 237
Ghrelin and Des-Acyl Ghrelin Promote Differentiation and Fusion of C2c12 Skeletal Muscle Cells 214
Hepatocyte Growth Factor-mediated satellite cells niche perturbation promotes development of distinct sarcoma subtypes 208
Sustained Met signalling in the heart leads to cardiac compensated hypertrophy and remodelling, which evolves into congestive heart failure 186
Ghrelin induces differentiation and fusion of C2C12 myoblasts and protects myotubes from atrophy 186
Activated Met Signalling in the Developing Mouse Heart Leads to Cardiac Disease 182
Agonist antibodies activating the Met receptor protect cardiomyoblasts from cobalt chloride-induced apoptosis and autophagy 169
A New Transgenic Mouse Model of Heart Failure and Cardiac Cachexia Raised by Sustained Activation of Met Tyrosine Kinase in the Heart 167
Hepatocyte growth factor regulates migration of olfactory interneuron precursors in the rostral migratory stream through Met-Grb2 coupling. 137
Equine T lymphocytes express MHC class II antigens. 126
[Analysis of a sample of the Italian population for HLA-DR antigen. Gene frequencies and gametic associations] 126
Bortezomib-mediated proteasome inhibition as a potential strategy for the treatment of rhabdomyosarcoma 124
[Association between HLA antigens and juvenile dermatitis herpetiformis] 122
Conditional activation of met in differentiated skeletal muscle induces atrophy 122
Gene expression profiling of HGF/Met activation in neonatal mouse heart 116
Cellular and molecular mechanisms of HGF/Met in the cardiovascular system 114
RNAi technology and lentiviral delivery as a powerful tool to suppress Tpr-Met-mediated tumorigenesis 114
HGF receptor agonists protect cardiomyocytes from CoCl2-induced cell injury 113
A xenogeneic monoclonal antibody recognizing specificities controlled by HLA-A and B alleles. 110
Validation of met as a therapeutic target in alveolar and embryonal rhabdomyosarcoma 108
Cardiac concentric hypertrophy promoted by activated Met receptor is mitigated in vivo by inhibition of Erk1,2 signalling with Pimasertib 107
HGF/Met tyrosine kinase receptor in heart physiology and pathophysiology 104
[Preliminary serological analysis for identification of direct monoclonal antibodies against surface structures of HLA typed human lymphocytes] 101
HGF-mediated modulation of Connexin 43 in cardiac cells 101
ERK: A key player in the pathophysiology of cardiac hypertrophy 100
Cardiac glycosides as new modulators of cholesterol metabolism 99
An In vivo Model of Met-Driven Lymphoma as a Tool to Explore the Therapeutic Potential of Met Inhibitors 99
Anti-Differentiation Effect of Oncogenic Met Receptor in Terminally-Differentiated Myotubes 98
Identification of novel circulating microRNAs in advanced heart failure by next-generation sequencing 98
Mek1 inhibition in vivo mitigates progressive cardiac concentric hypertrophy promoted by activated Met receptor. 97
HGF receptor agonists protect cardiomyocytes from CoCl2-induced cell injury 95
Characterization by monoclonal antibodies of lymphocyte subsets present in B-enriched suspensions. 95
Conditional expression of the Met oncogene in skeletal muscle induces severe atrophy in mice 95
The oncogenic transcription factor PAX3-FKHR can convert fibroblasts into contractile myotubes 94
Alloantisera with apparent HLA-A specificity reacting only against phytohemagglutinin-activated cells. 92
RNAI AS A TOOL TO SUPPRESS TPR-MET MEDIATED TUMORIGENESIS 92
Conditional expression of activated met in differentiated skeletal muscle induces atrophy 92
Chronic active hepatitis B. Interferon-activated natural killer-like cells against a hepatoma cell line transfected with the hepatitis B virus nucleic acid. 92
Met activation for cardioprotection against anthracycline cardiotoxicity. 91
Activation of the MET receptor attenuates doxorubicin-induced cardiotoxicity in vivo and in vitro 90
Emerging role of hepatocyte growth factor in cardiac function 87
Factor XII protects neurons from apoptosis by epidermal and hepatocyte growth factor receptor-dependent mechanisms 86
HGF/c-Met in postnatal heart development 84
A mouse model for spatial and temporal expression of HGF in the heart 84
New mouse models to study HGF/Met role in postnatal heart development and heart disease pathogenesis 84
Digoxin and ouabain induce the efflux of cholesterol via LXR signalling and the synthesis of ATP in cardiomyocytes. 83
Met activation for cardioprotection against anthracyclines cardiotoxicity 82
Signaling to cardiac hypertrophy: insights from human and mouse RASopathies 81
C-terminal truncated forms of Met, the hepatocyte growth factor receptor. 81
Cytolitic activity of monoclonal antibodies strongly depends on rabbit complement used. 80
Cardiac expression of hepatocyte growth factor increases adultneovascularization 80
Cardiac glycosides modulate cholesterol metabolism via SREBP-2 and LXR activation 80
New mouse models to study pathological consequences of chronical activation of HGF/c-MET axis specifically in the heart 78
Gain-of-function mouse models of the hgf/met axis reveal cardiac defects 78
TRUNCATED FORMS OF THE HEPATOCYTE GROWTH FACTOR (HGF) RECEPTOR 77
A new duplication at the C4B locus associated with the HLA-Aw68, Cw8, Bw65 haplotype. 76
The long-lasting protective effect of HGF in cardiomyoblasts exposed to doxorubicin requires a positive feed-forward loop mediated by ERK1,2-TIMP1-STAT3 76
[Current status of research on specific monoclonal xenoantibodies against human histocompatibility antigens] 74
Conditional expression of hepatocyte growth factor in cardiac and skeletal muscle for regeneration studies 74
HGF and MET: From Brain Development to Neurological Disorders 74
Agonistic monoclonal antibodies against the Met receptor dissect the biological responses to HGF. 73
Analysis of Mlc-lacZ Met mutants highlights the essential function of Met for migratory precursors of hypaxial muscles and reveals a role for Met in the development of hyoid arch-derived facial muscles 73
[Polymorphic determinants of HLA-A, B molecules analysed with monoclonal antibodies: serologic characterization and evaluation of technical variations] 72
Conditional expression of hepatocyte growth factor in cardiac and skeletal muscle for regeneration studies 72
PAX3-FKHR at the cross-road between differentiation and transformation 72
Overexpression of c-met protooncogene product and raised Ki67 index in hepatocellular carcinomas with respect to benign liver conditions. 70
Emerging role of hepatocyte growth factor in cardiac function 69
HGF/Met Axis in Heart Function and Cardioprotection 69
Cardiac expression of hepatocyte growth factor increases adult neovascularization 69
Quantitative expression of HLA class I molecules in acute non-lymphoblastic leukaemia cells. 67
HGF/Met axis has anti-apoptotic and anti-autophagic function in hypoxic cardiac injury 67
Engineering, Characterization, and Biological Evaluation of an Antibody Targeting the HGF Receptor 67
Activated human T cells express beta 2-microglobulin-associated HLA-A,B,C molecules not recognized by W6/32 mAb. 66
The monoclonal antibody AC1.59 defines a new polymorphic determinant on HLA-DR molecules. 66
Selective expression of the Met/HGF receptor in human central nervous system microglia 64
Molecular engineering strategies tailoring the apoptotic response to a met therapeutic antibody 64
[Different cytotoxic reactivity of anti-HLA A or B sera against sub-population of human lymphocytes prepared with different methods] 62
Mice with inducible cardiomyocyte expression of hepatocyte growth factor develop sistoli contractile dysfunction 61
New HLA class I-like alloantigens expressed on blast cells. 59
Contribution of monoclonal antibodies to the study of HLA class I antigens. 58
Identification of anti-DQ alloantisera correlated with DR5. 57
Inhibition of DNA replication and growth of several human and murine neoplastic cells by aphidicolin without detectable effect upon synthesis of immunoglobulins and HLA antigens. 57
Targeting of the SF/HGF receptor to the basolateral domain of polarized epithelial cells. 57
IEF analysis of HLA molecules immunoprecipitated by putative anti-class I-like alloantisera. 56
HLA class I- like antigen expression on human leukemic cells. 55
Generation of a truncated hepatocyte growth factor receptor in the endoplasmic reticulum 55
New HLA antigenic determinant shared by A2 and a subtype of Bw16 molecules detected by a monoclonal antibody. 54
Effect of hepatocyte growth factor on assembly of zonula occludens-1 protein at the plasma membrane. 52
Novel therapy for myocardial infarction: can HGF/Met be beneficial? 52
Expression of class I-like alloantigens on leukemic cells is not correlated with the amount of HLA-A,B,C molecules. 51
Expression of HLA class I antigens in human tumors and their involvement in tumor growth. 51
Further antigenic determinants on HLA-A molecules. 49
Overexpression of the Met/HGF receptor in ovarian cancer. 49
The receptor encoded by the human c-MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors. 48
Hepatocyte growth factor acts as a motogen and guidance signal for gonadotropin hormone-releasing hormone-1 neuronal migration 42
Anti-met fab-fc for the treatment of a tumor and/or metastasis 39
MET Oncogene Controls Invasive Growth by Coupling with NMDA Receptor 38
Ligand-regulated binding of FAP68 to the hepatocyte growth factor receptor. 37
Totale 9.316
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.987
article - articoli 0
book - libri 0
conference - conferenze 7.837
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.824
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020552 0 0 0 0 0 0 125 60 149 110 70 38
2020/2021884 72 69 62 42 91 36 80 14 141 75 67 135
2021/20221.179 63 71 46 72 63 49 97 56 39 77 310 236
2022/20231.970 207 193 45 185 198 500 114 105 232 65 81 45
2023/2024762 130 165 32 47 35 105 32 34 8 33 52 89
2024/20251.170 15 132 68 230 607 117 1 0 0 0 0 0
Totale 9.596